on such a short-term, and thus the clinical relevance of short-term follow-up, is unclear.
The primary objectives of this study were to assess the extent of aneurysm growth and rupture risk during shortterm follow-up in a group of patients with conservatively treated unruptured intracranial aneurysms. In addition, the association between patient-and aneurysm-specific factors and both aneurysm growth and rupture was evaluated.
Methods

Patient Selection
The study protocol was approved by the local institutional research ethics board, and informed consent was obtained as required. Our prospectively maintained neurovascular registry was queried to identify patients with unruptured saccular intracranial aneurysms between 1998 and 2017. Patients at least 18 years old with one or more unruptured intracranial aneurysms were included. We defined short-term follow-up as follow-up imaging between 3 months and 2 years after initial evaluation. Extradural aneurysms (e.g., located in the cavernous sinus) and aneurysms that were treated during follow-up were excluded, as well as patients for whom follow-up imaging was not available.
Patient Data
Patients' medical records and a questionnaire were used to collect the following baseline characteristics: age and sex of the patient at the time of initial evaluation, as well as a history of SAH from a different aneurysm, aneurysm multiplicity, cigarette smoking, use of acetylsalicylic acid, familial intracranial aneurysms, hypertension, autosomal-dominant polycystic kidney disease (ADPKD), and alcohol abuse. If a patient did not return the questionnaire, the patient's medical record was reviewed for baseline information. Hypertension was considered present if a patient had a previous diagnosis of hypertension or used antihypertensive medication. A positive familial predisposition was considered present if at least 2 first-degree relatives experienced intracranial aneurysms or SAHs. Alcohol abuse was defined as the weekly consumption of at least 300 g ethanol. We contacted the general practitioner of patients who did not return the questionnaire to verify whether the patient was still alive and to exclude possible rupture of the aneurysm. Study data were collected and managed using REDCap (Research Electronic Data Capture) electronic data capture tools hosted at our institution.
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Aneurysm Measurements
We measured the size of all aneurysms at baseline and at follow-up. Imaging studies consisted mostly of MRA with 3D time-of-flight sequences with 0.6-mm slice thickness, and contrast-enhanced CTA with 0.75-mm slice thickness. If patients underwent multiple follow-up scanning sessions within the interval for short-term follow-up, the most recent scan was used as the follow-up scan. We used syngo.via radiological software (version VB20A, Siemens Healthcare) to perform all measurements. Aneurysm height, width, and neck diameter were measured. We defined height as the largest distance from the center of the neck to the tip of the aneurysm dome. Aneurysm width was measured perpendicular to the height. Aspect ratio was calculated by dividing the maximum height, measured perpendicular to the neck of the aneurysm, by the neck diameter (Fig. 1) . 21 Size ratio was calculated by dividing the maximum height of the aneurysm by the average parent artery diameter. 4 All aneurysm measurements were performed by one author (R.M.). The findings of the researcher were always compared to the findings of the neuroradiologist who reviewed the imaging during follow-up. The measurements of enlarged aneurysms were also assessed by a second reviewer (M.W.A.). When there was a discrepancy between the assessment of the reviewer and the neuroradiologist, an experienced neuro-interventionalist (M.U.) reviewed the measurements and made a final decision.
Outcome
The primary outcomes were growth or rupture during follow-up. Aneurysm growth was defined as either an increase in size of ≥ 1 mm in at least one direction or a change from a regular to an irregular shape. 1 The latter was defined as the presence of blebs, multiple lobes, or wall protrusions, as previously described by Backes et al. 2 Shape assessment was performed using 3D reconstructions of the MRA and CTA images, which were previously shown to adequately assess aneurysm shape.
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Statistical Analysis
Descriptive statistics were used to describe the baseline characteristics for the group of patients with stable aneurysms and for the group with aneurysm growth or rupture. The Student t-test or Mann-Whitney U-test was used as appropriate to evaluate differences in baseline characteristics for continuous variables. Fisher's exact test was used for categorical variables. We calculated relative risks with 95% confidence intervals to identify factors associated with an increased likelihood of aneurysm growth or rupture during short-term follow-up; p < 0.05 was used as the limit for statistical significance. We used IBM SPSS (version 23.0, IBM Corp.) to perform the analyses.
Results
Baseline Characteristics
A total of 206 patients with 267 aneurysms met the inclusion criteria (Table 1) . Twenty-two of the 206 patients had died by the time this study was conducted. Of these, 2 patients died of an SAH outside the short-term follow-up interval, 1 patient died of an SAH from an additional previously electively coiled aneurysm, and 1 patient died suddenly, potentially due to aneurysm rupture. The remaining 18 patients died of reasons unrelated to the intracranial aneurysm. Sixty-eight percent of patients who were still alive returned the questionnaire. The median age at initial presentation was 56 years (range 28-79 years), and the median interval between diagnosis and short-term followup was 1 year (range 0.3-2 years). The mean aneurysm size at initial evaluation was 4.7 mm (SD 2.8 mm).
Aneurysm Growth
Seven of 267 aneurysms (2.6%, 95% CI 1.2%-5.6%) enlarged during short-term follow-up (Table 2) . Growth was detected after a median follow-up period of 1.1 years (range 0.8-1.6 years). Five patients were electively treated after growth was detected. One patient declined treatment. The remaining patient was not offered treatment, since growth was not detected by the radiologist during followup. However, during this study we detected the formation of a bleb during follow-up, based on which we described the aneurysm as enlarged. Treatment-associated complications occurred in 1 patient treated with stent-assisted coiling. This patient suffered an in-stent thrombosis shortly after discharge, with persistent neurological impairment at follow-up.
Aneurysm Rupture
One of 267 aneurysms (0.4%, 95% CI 0.0%-2.4%) ruptured 10 months after initial discovery (case 2). It was an anterior communicating artery aneurysm in a 79-year-old man with a maximum diameter of 22 mm at diagnosis. The aneurysm was left untreated at initial presentation due to the patient's age in combination with extensive comorbidities and intraaneurysmal thrombosis increasing the treatment-associated risks. At the time of rupture, the maximum diameter had increased to 30 mm. The patient did not survive the rupture.
Risk Factors
Patients with aneurysm growth or rupture were older than patients with stable aneurysms (median age 64 vs 56 years, p = 0.04). The presence of ADPKD was statistically significant for a higher likelihood of growth or rupture during short-term follow-up (RR 8.3, 95% CI 2.0-34.7), as well as an aspect ratio > 1.6 or size ratio > 3 (RR 10.8, 95% CI 2.2-52.2), and an initial size ≥ 7 mm (RR 10.7, 95% CI 2.7-42.8).
Discussion
In this study, we found that aneurysm growth during short-term follow-up does occur in a small proportion of aneurysms (2.6%). The majority of aneurysm growth and the single aneurysm rupture occurred in aneurysms larger than 7 mm. In addition to initial size, ADPKD and an aspect ratio > 1.6 or size ratio > 3 were associated with an increased likelihood of aneurysm growth or rupture. Enlarged aneurysms were nearly always electively treated soon after detection. Thus, short-term follow-up facilitates the detection of around 2 to 3 high-risk aneurysms for every 100 patients with a diagnosed unruptured intracranial aneurysm. Two other studies investigated the yield of short-term follow-up for unruptured intracranial aneurysms during a relatively short follow-up period. 10, 25 Wermer et al. evaluated the yield of short-term screening in unruptured aneurysms smaller than 5 mm that were detected during screening after an SAH or because of the presence of familial aneurysms. 25 They identified growth in 3 (2.4%) of 125 aneurysms during a median follow-up duration of 1.3 years (range 0.7-3.8 years). One (0.8%) previously ruptured aneurysm reruptured during follow-up of additional unruptured aneurysms. A previous history of both SAH and the presence of familial aneurysms were found to be associated with an increased risk of growth or rupture during short-term follow-up. In contrast to our study, none of the aneurysms were treated, since growth was only very small. The authors argued that, given the low occurrence of growth, and the absence of clinical consequences in their cohort, short-term follow-up is not useful. In our study, we demonstrated that considerable aneurysm growth also occurs in relatively small aneurysms, underlining the clinical relevance of short-term follow-up, also for smaller aneurysms. Inoue et al. found a lower incidence of growth in 14 (1.1%) and rupture in 4 (0.3%) of 1325 aneurysms during a median follow-up duration of 1.0 year (range 0.4-1.9 years). 10 Growth or rupture regularly occurred in aneurysms smaller than 5 mm, with even 44% of enlarging aneurysms being smaller than 3 mm at initial presentation. The only variable linked to an increased risk of growth was female sex. The majority of aneurysms were treated after detection of growth.
The difference in frequency of aneurysm growth between both aforementioned studies may be partially attributed to the use of different measurement protocols and criteria for aneurysm growth. Wermer et al. systematically measured aneurysms in 2 directions and noted growth as an increase of at least 0.5 mm in at least one direction, while Inoue et al. only measured the maximum diameter, used low-resolution MRA, and consequently described aneurysms as enlarged after an increase in maximum diameter of least 1.5 times or after a change in aneurysm morphology.
Study Strengths and Limitations
Strengths of this study include the use of a strict measurement protocol to detect aneurysm growth during a predefined short-term follow-up period. Also, all patients referred to our center with an indication for follow-up imaging are routinely recommended follow-up imaging after 1 year, limiting the risk of a selection bias among conservatively treated aneurysms in our cohort. In addition, we calculated aspect and size ratios for all aneurysms; these calculations have not been described in previous studies regarding shortterm follow-up but were shown to be associated with an increased likelihood of aneurysm growth or rupture in our study. Several limitations should also be addressed. The major limitation of this study is the retrospective nature of the data collection, which can potentially lead to misclassification of patients with regard to the presence or absence of specific risk factors. For a proportion of patients, mainly those who previously experienced an SAH, change in aneurysm size was assessed using multiple imaging modalities. Recent research showed no significant inter-and intraobserver variability between CTA-and MRA-based aneurysm size measurements. 13 This suggests that changes in aneurysm size can be accurately assessed between the two different imaging modalities. Also, although we described aneurysm growth in a relatively large cohort, we were unable to perform multivariate statistical analysis due to the small number of growing aneurysms and aneurysm rupture that occurred during follow-up. 23 Furthermore, we included patients with and without a history of a previous SAH, although the mechanisms underlying aneurysm progression may be different for these groups. However, although around 40% of the patients in our cohort previously experienced an SAH, this was not associated with a statistically significant higher likelihood of aneurysm growth.
Conclusions
Growth of unruptured intracranial aneurysms occurs during short-term follow-up. As aneurysm growth is associated with an increased risk of rupture, we believe that short-term follow-up is clinically relevant and has an important role in reducing the risk of a potential SAH.
